E Fund Management »

Aeglea Biotherapeutics shares owned by E Fund Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by E Fund Management from 13F filings

Historical chart of E Fund Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by E Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by E Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $361k 7.2k 50.44

More positions owned by E Fund Management

Pdd Holdings Sponsored Ads (PDD)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Lumentum Hldgs (LITE)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Corning Incorporated (GLW)
Axt (AXTI)
Broadcom (AVGO)
Tower Semiconductor Shs New (TSEM)
Micron Technology (MU)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Asml Hldg Nv N Y Registry Shs (ASML)

View all positions for E Fund Management

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Vanguard Group
Fairmount Funds Management
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Driehaus Capital Management
State Street Corporation
Paradigm Biocapital Advisors
Commodore Capital
TCG Crossover Management
Tang Capital Management
Capital Research and Management Company - Division 3

View all funds holding Aeglea Biotherapeutics